XML 43 R32.htm IDEA: XBRL DOCUMENT v3.25.2
Basis of Presentation - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Sep. 11, 2024
Feb. 25, 2024
Sep. 30, 2024
Feb. 29, 2024
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Sep. 11, 2025
Jul. 31, 2025
Subsidiary, Sale of Stock [Line Items]                      
Accumulated Deficit         $ 302,817,000   $ 302,817,000   $ 268,195,000    
Net cash used in operating activities             (8,170,000) $ (6,721,000)      
Cash and cash equivalents         $ 21,827,000 $ 15,363,000 21,827,000 $ 15,363,000 $ 20,245,000    
Subsequent Event                      
Subsidiary, Sale of Stock [Line Items]                      
Extension period (in days)                     90 days
WTI Loan Facility | Term Loan                      
Subsidiary, Sale of Stock [Line Items]                      
Term loan facility $ 15,000,000                    
WTI Loan Facility | Term Loan | Subsequent Event                      
Subsidiary, Sale of Stock [Line Items]                      
Extension period (in days)                     90 days
WTI Loan Facility | Term Loan | First Tranche Commitment                      
Subsidiary, Sale of Stock [Line Items]                      
Term loan facility 10,000,000                    
Proceeds from long-term borrowings             $ 7,500,000        
ABL Line of Credit | Line of Credit | Revolving Credit Facility                      
Subsidiary, Sale of Stock [Line Items]                      
Maximum borrowing capacity $ 15,000,000                    
ABL Line of Credit | Line of Credit | Revolving Credit Facility | Forecast                      
Subsidiary, Sale of Stock [Line Items]                      
Maximum borrowing capacity                   $ 20,000,000  
Additional maximum borrowing capacity                   $ 5,000,000  
Three Largest Customers | Customer Concentration Risk | Accounts Receivable                      
Subsidiary, Sale of Stock [Line Items]                      
Concentration risk percentage             83.00%   63.00%    
Customer 1 | Customer Concentration Risk | Revenue Benchmark                      
Subsidiary, Sale of Stock [Line Items]                      
Concentration risk percentage         64.00% 42.00% 52.00% 35.00%      
Customer 1 | Customer Concentration Risk | Accounts Receivable                      
Subsidiary, Sale of Stock [Line Items]                      
Concentration risk percentage             68.00%        
Customer 2 | Customer Concentration Risk | Revenue Benchmark                      
Subsidiary, Sale of Stock [Line Items]                      
Concentration risk percentage           10.00%   14.00%      
Customer 3 | Customer Concentration Risk | Revenue Benchmark                      
Subsidiary, Sale of Stock [Line Items]                      
Concentration risk percentage           10.00%          
September 2024 Offering                      
Subsidiary, Sale of Stock [Line Items]                      
Sale of stock, shares issued in transaction (in shares) 3,135,136                    
Proceeds received from issuance of common stock     $ 10,590,000                
Private Placement                      
Subsidiary, Sale of Stock [Line Items]                      
Sale of stock, shares issued in transaction (in shares) 750,000                    
Series B Convertible Preferred Stock | Private Placement                      
Subsidiary, Sale of Stock [Line Items]                      
Proceeds from issuance of preferred stock   $ 9,250,000   $ 9,250,000